GC

Gian Chand Singla

Director Director DIN 08509859
DIN 08509859 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2019
Shareholding value •••• Premium profile

About Gian Chand Singla

Data last updated:

Gian Chand Singla was a Director at Singlamedicos Pharma Private Limited (2019–2023) and Director at Singlamedicos Pharma Solutions Private Limited (2022–2023). The companies operate in Pharma.

DIN 08509859
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Singlamedicos Pharma Private Limited U51909TG2019PTC168657
Director15 Jul 20192019₹64.20 Cr (FY 2022)Amalgamated
Director25 Mar 20222022₹121 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Singlamedicos Pharma Private Limited
Singlamedicos Pharma Solutions Private Limited
Premium access

Shareholding and investment profile for Gian Chand Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gian Chand Singla

Gian Chand Singla was first appointed on 15 Jul 2019 as Director at Singlamedicos Pharma Private Limited. The most recent appointment on record is 25 Mar 2022 at Singlamedicos Pharma Solutions Private Limited.

Gian Chand Singla held 2 earlier board appointments: Singlamedicos Pharma Private Limited (Director, 15 Jul 2019 to 04 Jun 2023); Singlamedicos Pharma Solutions Private Limited (Director, 25 Mar 2022 to 04 Jun 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available